Paper7935686
Transforming growth factor beta in tissue fibrosis.
Border WA and 1 other. N Engl J Med, 1994. Cited by 2,872 papers, by iCite.
Cite this record
ConductScience Library. Transforming growth factor beta in tissue fibrosis. Papers, record 7935686. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7935686
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibrosis | Major topic |
| Transforming Growth Factor beta | Major topic |
| Animals | |
| Cytokines | |
| Humans | |
| Kidney | |
| Liver Cirrhosis | |
| Pulmonary Fibrosis | |
| Wound Healing |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| DK 43609 | NIDDK NIH HHS | United States | R01DK043609 | PubMed and NIH | NIH RePORTER |
| R37DK043609 | NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00001959 | Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis) | Background |
Source ClinicalTrials.gov
Cited by836
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,872 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943198 | Beyond Weight Loss and Glycemic Control: Molecular Mechanisms and Hypothesis-Generating Therapeutic Potential of Incretin-Based Therapies Against Peritoneal Fibrosis in Peritoneal Dialysis. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943198 | PubMed |
| 42830635 | Esaxerenone attenuates renal injury by inhibiting NR3C2-mediated inflammatory and fibrotic pathways. | Ren Fail | 2026 | https://conductscience.org/library/papers/42830635 | PubMed |
| 42738813 | Molecular Mechanisms of Intimal Hyperplasia in Saphenous Vein Grafts After Coronary Artery Bypass Grafting. | Cells | 2026 | https://conductscience.org/library/papers/42738813 | PubMed |
| 42712460 | Hypertension identified in early adulthood as an endocrine-vascular risk factor for uterine fibroids in reproductive-age women: a nationwide cohort study. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42712460 | PubMed |
| 42702797 | Cord Blood-Derived Platelet Gel in Wound Healing: From Biological Rationale to Clinical Application. | Wound Repair Regen | 2026 | https://conductscience.org/library/papers/42702797 | PubMed |
| 42642530 | Plasminogen activator inhibitor-1 promotes the proliferation and blocks TGF-β1-dependent growth inhibition of cholesteatoma keratinocytes by ERK signaling. | Eur Arch Otorhinolaryngol | 2026 | https://conductscience.org/library/papers/42642530 | PubMed |
| 42566007 | Effects of laparoscopic splenectomy and azygoportal disconnection on liver reserve function for cirrhosis patients: a 1-year prospective study. | Surg Endosc | 2026 | https://conductscience.org/library/papers/42566007 | PubMed |
| 42518044 | Mathematical Modeling of Systemic Sclerosis and Its Treatment. | Bull Math Biol | 2026 | https://conductscience.org/library/papers/42518044 | PubMed |
| 42481476 | Vactosertib plus pembrolizumab in patients with non-microsatellite instability-high metastatic colorectal or gastric cancer: a multicenter, phase Ib/IIa study. | Nat Commun | 2026 | https://conductscience.org/library/papers/42481476 | PubMed |
| 42385711 | Targeted DNA triplex-forming oligonucleotide liposome for pulmonary fibrosis gene therapy. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42385711 | PubMed |
| 42298564 | PPARγ signalling pathway: molecular mechanisms and therapeutic potential in ligamentum flavum hypertrophy and lumbar spinal stenosis. | J Transl Med | 2026 | https://conductscience.org/library/papers/42298564 | PubMed |
| 42143387 | EDL6D, a bioactive peptide phenocopying SHBG-associated metabolic effects: a new preclinical lead compound for treating the metabolic dysfunction-associated fatty liver disease. | J Transl Med | 2026 | https://conductscience.org/library/papers/42143387 | PubMed |
| 42094953 | Beyond attenuation: a translational review of curative-intent pharmacological targets in idiopathic pulmonary fibrosis. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42094953 | PubMed |
| 42042290 | Comparative Late Effects of Hemostatic Biomaterials on Wound Healing at 14 and 30 Days: An In Vivo Animal Study. | J Funct Biomater | 2026 | https://conductscience.org/library/papers/42042290 | PubMed |
| 41977373 | Cell-Targeted Inhibition of CaMK4 Suppresses Tertiary Lymphoid-like Structure Development in Lupus-Prone Mice. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977373 | PubMed |
| 41878126 | Inhalable TFRC-Targeted Extracellular Vesicles Delivery of siTGF-β1 Alleviates Pulmonary Fibrosis via Dual Inhibition of Ferroptosis and Fibroblast Activation. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41878126 | PubMed |
| 41682601 | Residual Renal Risk in Diabetic Nephropathy Despite Contemporary Therapies. | J Clin Med | 2026 | https://conductscience.org/library/papers/41682601 | PubMed |
| 41594645 | Efficacy of Modified Talc Powder in Experimental Rat Model of Pleurodesis. | Biomolecules | 2026 | https://conductscience.org/library/papers/41594645 | PubMed |
| 41567268 | Therapeutic Effects of Gallic Acid and Alpha-Tocopherol on Adenine-Induced Chronic Kidney Disease in Male Wistar Rats. | Biochem Res Int | 2026 | https://conductscience.org/library/papers/41567268 | PubMed |
| 41551214 | New frontiers in regenerative medicine: Protocol standardization and morphological assessment of leukocyte-platelet rich fibrin in cows, with a longitudinal study on growth factor release dynamics. | Vet Anim Sci | 2026 | https://conductscience.org/library/papers/41551214 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
| TGFBR2 | 7048 | PubTator's text mining | https://conductscience.org/library/genes/7048 | NCBI Gene |
| TGFBR3 | 7049 | PubTator's text mining | https://conductscience.org/library/genes/7049 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7935686
GET https://conductscience.org/api/papers/v1/7935686/cited_by?page=2